https://www.selleckchem.com/ALK.html
1 cm ; ≤ 0.01) were statistically significantly smaller. However, there was no difference in volume between ASA users (median 16.9 cm ; = 0.16) and patients with NDAF. The DOACs group was significantly different compared to the NDAF group in terms of NIHSS scores (median 4.4 vs 8.3; ≤ 0.01) and mRS scores at discharge (median 1.7 vs 2.7; ≤ 0.01), and period of hospitalization (median 6.4 vs 10.4 days; ≤ 0.01). We observe, while using DOACs, the infarct volumes of patients who experience stroke are smaller than those with NDAF and using ASA, as well
Like
Comment
Share
